This inventor holds 1 USPTO granted patent. Top assignee: Korea Greencross Corporation. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Innovations of Soon-Kwan Chung in Blood Coagulation Research
Introduction: Soon-Kwan Chung is a notable inventor based in Kyoungki-do, South Korea. He has made significant contributions to the field of blood coagulation through his innovative research and patented methods. His work focuses on enhancing the understanding and measurement of enzymatic activities related to blood coagulation factors.
Latest Patents: Soon-Kwan Chung holds a patent for a method of determining the enzymatic activity of blood coagulation factor XIII using purified fibrin monomer as a substrate. This invention relates to a technique that effectively measures the enzymatic activity by detecting the degree of cross-linking of fibrin monomer formed by the blood coagulation factor XIII. The method also involves obtaining fibrin monomer free of blood coagulation factor XIII through washing with a citric acid solution. This patent is crucial for validating other enzymatic assay methods for blood coagulation factor XIII and for characterizing this important factor.
Career Highlights: Soon-Kwan Chung is associated with Korea Greencross Corporation, where he applies his expertise in blood coagulation research. His work has implications for both clinical and laboratory settings, enhancing the understanding of coagulation processes and potential therapeutic applications.
Collaborations: He has collaborated with notable colleagues, including Hee-Chul Kim and Shin-Jae Chang, contributing to advancements in their shared field of research.
Conclusion: Soon-Kwan Chung's innovative methods in blood coagulation research exemplify the importance of scientific inquiry and patenting in advancing medical knowledge. His contributions are vital for improving diagnostic and therapeutic strategies in coagulation disorders.